Mead Johnson Nutrition (MJN) Q1 2012 Earnings Call April 26, 2012 9:30 am ET Executives Kathy Ann MacDonald - Acting Corporate Controller and Vice President of Investor Relations Stephen W. Golsby - Chief Executive Officer, President and Director Peter Kasper Jakobsen - President of Americas Operations Peter G. Leemputte - Chief Financial Officer and Executive Vice President Analysts Matthew C. Grainger - Morgan Stanley, Research Division Edward Aaron - RBC Capital Markets, LLC, Research Division Varun Gokarn - Goldman Sachs Group Inc., Research Division John Baumgartner Timothy S. Ramey - D.A. Davidson & Co., Research Division Jon Andersen - William Blair & Company L.L.C., Research Division Leigh Ferst - Wellington Shields & Co., LLC, Research Division Robert Moskow - Crédit Suisse AG, Research Division Alexis Borden - Citigroup Inc, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition First Quarter 2012 Earnings Conference Call. My name is Shikwana, and I will be your coordinator for today. [Operator Instructions] I would Now like to turn the presentation over to Kathy MacDonald, Vice President, Investor Relations. Please proceed, Kathy. Kathy Ann MacDonald Thank you, and good morning. Welcome to Mead Johnson's first quarter conference call. Speaking today will be Steve Golsby, our Chief Executive Officer; Pete Leemputte, our Chief Financial Officer; and Kasper Jakobsen, our recently appointed Chief Operating Officer. Before we get started, let me remind you that our comments will include forward-looking statements about our future results, including statements about our financial prospects and projections, new product launches and market conditions, that constitute forward-looking statements for purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.